TITLE

First patients treated with vProtect

PUB. DATE
July 2008
SOURCE
Cardiovascular Devices & Drugs;Jul2008, Vol. 14 Issue 7, p23
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article reports on the first administration of the vProtect Luminal Shield self-expanding intracoronary prosthesis from Prescient Medical in May 2008. Three patients with established cardiac ischemia were the first recipients of the prosthesis which was designed to limit arterial injury resulting from the deployment of stents. The first patients were treated by doctors Juan Granada and Juan Delgado. It cites the features of the prosthesis which include longitudinal primary structural elements.
ACCESSION #
33516937

 

Related Articles

  • First 3 patients treated with new self-expanding stent. Pedersen, Amanda // Medical Device Daily;6/2/2008, Vol. 12 Issue 105, p1 

    The article reports on the enrolment of three patients with cardiac ischemia in a clinical trial for the vProtect Luminal Shield, an intracoronary prosthesis that is said to be capable of limiting arterial injuries caused by the deployment of stents. According to Shield developer Prescient...

  • TCT notebook.  // Medical Device Daily;10/25/2007, Vol. 11 Issue 205, p3 

    The article presents the four-month results for Excella, a first-in-man clinical trial of the Novolimus-eluting coronary stent, reported by Elixir Medical, a developer of drug-eluting stent platforms in Sunnyvale, California. Findings show that the Novolimus system was effective in reducing...

  • ISAR LEFT MAIN: Paclitaxel-eluting stent noninferior to sirolimus-eluting stent for unprotected left main disease.  // Cardiology Today;Dec2008, Vol. 11 Issue 12, p16 

    The article discusses the results of the ISAR LEFT MAIN trial, which suggested that paclitaxel-eluting stent was noninferior to the sirolimus-eluting stent in patients with unprotected left main coronary artery disease. Similar target lesion revascularization between those receiving the...

  • Catheter-based prostacyclin synthase gene transfer prevents in-stent restenosis in rabbit atheromatous arteries Numaguchi, Yasushi; Okumura, Kenji; Harada, Mitsunori; Naruse, Keiji; Yamada, Michiharu; Osanai, Hiroyuki; Matsui, Hideo; Ito, Masafumi; Murohara, Toyoaki // Cardiovascular Research;Jan2004, Vol. 61 Issue 1, p177 

    Objective: Prostacyclin synthase (PGIS) gene transfer have been shown to accelerate re-endothelialization and prevent neointimal formation in balloon-injured arteries. The aim of this study is to evaluate how overexpression of endogenous prostacyclin exerts those beneficial effects in...

  • Developmental origin of age-related coronary artery disease. Ke Wei; Díaz-Trelles, Ramon; Qiaozhen Liu; Diez-Cuñado, Marta; Scimia, Maria-Cecilia; Wenqing Cai; Sawada, Junko; Komatsu, Masanobu; Boyle, Joseph J.; Bin Zhou; Ruiz-Lozano, Pilar; Mercola, Mark // Cardiovascular Research;7/15/2015, Vol. 107 Issue 2, p287 

    Aim: Age and injury cause structural and functional changes in coronary artery smooth muscle cells (caSMCs) that influence the pathogenesis of coronary artery disease. Although paracrine signalling is widely believed to drive phenotypic changes in caSMCs, here we show that developmental origin...

  • Carotid Artery Stents for Blunt Cerebrovascular Injury. Eskandari, Mark K. // Perspectives in Vascular Surgery & Endovascular Therapy;Mar2006, Vol. 18 Issue 1, p73 

    The authors analyzed a prospective database of patients with blunt carotid artery injuries to determine if carotid stenting is a safe and effective treatment. Patients with certain injury patterns underwent angiography to screen for blunt CAI in patients with certain injury patterns....

  • Endovascular management of axillosubclavian artery injuries: report of three cases. Leong, Benjamin; Naresh, Govindarajanthran; Hanif, Hussein; Lee, Soon; Zainal, Ariffin; Sara, Chelwan // Surgery Today;Aug2013, Vol. 43 Issue 8, p918 

    Open surgical repair of axillosubclavian artery injuries is technically demanding and associated with significant morbidity and mortality. Endovascular intervention has emerged as a valuable alternative to open surgical repair. This report presents three cases with axillosubclavian artery...

  • Endovascular Stent for Iatrogenic Penetrating Injury of the Thoracic Aorta. Bozzani, Antonio // Vascular & Endovascular Surgery;Jul2014, Vol. 48 Issue 5/6, p438 

    A letter to the editor is presented in response to the article "Endovascular Stent for Iatrogenic Penetrating Injury of the Thoracic Aorta" by P. A. Vagefi, M. S. Patel and G. M. La Muraglia, which appeared in a previous issue of the journal.

  • STANCE: OCT assessment confirms safety of bioresorbable scaffold in SFA lesions.  // Cardiology Today;Dec2012, Vol. 15 Issue 12, p31 

    The article discusses the STANCE First-in-Human study presented by physician Andrew Holden at the Vascular Interventional Advances meeting held from October 9 to 12, 2012 in Las Vegas, Nevada, which showed the safety of a stent with a bioresorbable scaffold in superficial femoral artery lesions.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics